Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Appointed director
CC transcript
Life Technologies Corp (LIFE) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/02/2012 8-K/A Quarterly results
Docs: "Life Technologies Corporation amended and revised press release"
02/29/2012 8-K/A Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results"
02/10/2010 8-K/A Quarterly results
Docs: "Life Technologies Corporation condensed consolidated balance sheets as of December 31 2009 and 2008"
02/05/2010 8-K/A Financial Statements and Exhibits
06/23/2008 8-K/A Other Events, Financial Statements and Exhibits
Docs: "AGREEMENT AND PLAN OF MERGER"
04/27/2006 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Incentive Stock Option Agreement",
"Nonstatutory Stock Option Agreement",
"Restricted Stock Units Agreement"
11/05/2004 8-K/A Financial Statements and Exhibits
Docs: "Invitrogen Corporation and BioReliance Corporation Unaudited Pro Forma Combined Statement of Income for the nine months ended September 30, 2004, and related Notes to Combined Financial Statement"
09/02/2004 8-K/A Financial Statements and Exhibits
Docs: "Invitrogen Corporation and BioReliance Corporation Unaudited Pro Forma Combined Statement of Income for the six months ended June 30, 2004, and related Notes to Combined Financial Statement"
05/25/2004 8-K/A Financial statements and exhibits
Docs: "Invitrogen Corporation and BioReliance Corporation Unaudited Pro Forma Combined Statement of Income for the three months ended March 31, 2004, and related Notes to Combined Financial Statement"
04/21/2004 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
Docs: "Consent of Independent Accountants",
"BioReliance Corporation audited (i) Consolidated Balance Sheet as of December 31, 2003; (ii) Consolidated Statement of Income for the year ended December 31, 2003; (iii) Consolidated Statement of Changes in Shareholders' Equity for the year ended December 31, 2003; (iv) Consolidated Statement of Cash Flows for the year ended December 31, 2003; and related Notes to Consolidated Financial Statements",
"Invitrogen Corporation and BioReliance Corporation Unaudited Pro Forma (i) Combined Balance Sheet as of December 31, 2003; (ii) Combined Statement of Income for the year ended December 31, 2003; and (iii) related Notes to Combined Financial Statements"
10/31/2003 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
Docs: "Consent of Independent Accountants",
"Molecular Probes, Inc., and Subsidiaries audited (i) Consolidated Balance Sheet as of September 30, 2002; (ii) Consolidated Statement of Income for the year ended September 30, 2002; (iii) Consolidated Statement of Changes in Shareholders' Equity for the year ended September 30, 2002; (iv) Consolidated Statement of Cash Flows for the year ended September 30, 2002; and related Notes to Consolidated Financial Statements",
"Molecular Probes, Inc., and Subsidiaries unaudited (i) Consolidated Balance Sheet as of June 30, 2003; (ii) Consolidated Statements of Income for the nine months ended June 30, 2003 and 2002; and (iii) Consolidated Statements of Cash Flows for the nine months ended June 30, 2003 and 2002; and related Notes to Unaudited Consolidated Financial Statements",
"Invitrogen Corporation and Molecular Probes, Inc., Unaudited Pro Forma (i) Combined Balance Sheet as of June 30, 2003; (ii) Combined Statements of Income for the six months ended June 30, 2003, and for the year ended December 31, 2002; and (iii) related Notes to Combined Financial Statements"
06/10/2003 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
Docs: "Consent of PricewaterhouseCoopers LLP",
"PanVera Acquired Business audited (i) Balance sheet as of December 31, 2002; (ii) Statement of Income and Comprehensive Income for the year ended December 31, 2002; (iii) Statement of Cash Flows for the year ended December 31, 2002; and (iv) related Notes to Financial Statements",
"Invitrogen Corporation and PanVera Acquired Business Unaudited Pro Forma (i) Combined Balance Sheet as of December 31, 2002; (ii) Combined Statement of Income for the year ended December 31, 2002; and (iii) related Notes to Combined Financial Statements"
04/24/2002 8-K/A Changes in registrant's certifying accountant, Financial statements and exhibits
02/17/2000 8-K/A Acquisition or disposition of assets, Other events, Financial statements and exhibits
09/14/1999 8-K/A Acquisition or disposition of assets, Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy